Lindahl advises Senzime AB on a directed new share issue of SEK 100 million
Lindahl has advised Senzime AB (publ) in connection with a directed new share issue that will provide the company with SEK 100 million before transaction costs.
The subscription price was determined through an accelerated bookbuilding process, with Carnegie Investment Bank acting as financial adviser.
About Senzime
Senzime AB is a company listed on Nasdaq Stockholm that develops and markets CE and FDA approved monitoring systems for patients undergoing anaesthesia.
Lindahl's team consisted of Mattias Prage, Andreas Mellberg and Michaela Larsson.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatMichaela Larsson
Associate | AdvokatAndreas Mellberg
Counsel | AdvokatCarousel items
-
Knowledge
3/16/2026
New system for coordinated register checks in public procurement
The Government has proposed a new system for coordinated register checks in public procurement, with a proposed entry into force on 1 July 2026.
-
Cases and transactions
3/11/2026
Lindahl advises Jajum AB and OssAv AB on the sale of Amplius Omsorg AB
Lindahl advised Jajum AB and OssAv AB on the sale of Amplius Omsorg AB, active within residential care, sheltered housing and foster care, to Sekoya AS.
-
News articles
2/12/2026
Lindahl ranked in Chambers and Partners Global Guide 2026
Lindahl is proud to once again be ranked in Chambers and Partners Global Guide. This year's ranking confirms the firm's strong position within several business-critical practice areas.
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?
